Some low molecular weight alcohols of industrial importance are produced by the addition of water to alkenes. 24034-73-9, formula is C20H34O, Ethanol, isopropanol, 2-butanol, and tert-butanol are produced by this general method. Two implementations are employed, the direct and indirect methods. Name: (2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-ol
Nunes Alves Paim, Luis Fernando;Patrocinio Toledo, Cassio Augusto;Lima da Paz, Joicelene Regina;Picolotto, Aline;Ballardin, Guilherme;Souza, Vinicius Castro;Salvador, Mirian;Moura, Sidnei research published 《 Connaraceae: An updated overview of research and the pharmacological potential of 39 species》, the research content is summarized as follows. A review. An interdisciplinary scientific investigation of biol. active agents is fundamental to search for natural substances with therapeutic action. This review collected the most relevant information on traditional knowledge related to the use of plants of the Connaraceae family. This work is the first to compile all the published ethnobotanical, chem., pharmacol., and toxicol. information about this important plant family. Aim of the study: Our objective was to provide the scientific community with an up-to-date overview of the pharmacol. potential of Connaraceae species. We searched NCBI Pubmed Central, Google Scholar, Scientific Electronic Library Online (SciELO), ScienceDirect, SciFinder, and Scopus databases to review the research on ethnobotanical, chem., pharmacognostical, pharmacol., and toxicol. studies with Connaraceaes. Books that address the theme were also included. The literature review indicated that 39 species of Connaraceaes have pharmacol. potentiality. Ethnobotany reports listed 36 of the 39 species discussed. Pharmacognostical studies have been conducted with 23 species and isolates, and chem. compounds have been identified for only 15 species. At least one study has been published concerning the pharmacol. activities for 20 of the 39 species analyzed. For Agelaea pentagyna, Cnestis ferruginea, Connars suberosus, and Rourea minor, pharmacol. activity experiments were performed using isolated compounds, which have the highest current pharmacol. potential. Studies employing a toxicol. approach cover only 10 of the 39 Connaraceaes species. Thus, scientific community should conduct much more research for a broader understanding of this plant family.
Name: (2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-ol, Geranylgeraniol is a diterpenoid that is hexadeca-2,6,10,14-tetraene substituted by methyl groups at positions 3, 7, 11 and 15 and a hydroxy group at position 1. It has a role as a plant metabolite, a volatile oil component and an antileishmanial agent. It is a diterpenoid and a polyprenol.
Geranylgeraniol, a precursor to geranylgeranylpyrophosphate, is an intermediate in the mevalonate pathway. Geranylgeraniol has been shown to prevent bone re-absorption, inhibition of osteoclast formation, and kinase activation in vitro. When working with statins, Geranylgeraniol can reduce the toxicity without inhibiting the cholesterol-producing effects. Geranylgeraniol has been documented to counteract the effects of fluvastatin by inhibiting activation of caspase-1 and production of IL-1. Additionally Geranylgeraniol has been found to induce apoptosis in HL-60 cells.
, 24034-73-9.
Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts